- Home
- NRXP vs GNTA Comparison
NRXP vs GNTA Comparison
Compare NRXP & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRXP | GNTA |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.7M | 39.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | NRXP | GNTA |
|---|---|---|
| Price | $2.36 | $1.89 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $30.50 | N/A |
| AVG Volume (30 Days) | ★ 446.3K | 122.5K |
| Earning Date | 11-17-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $242,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $643.59 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.15 | $1.35 |
| 52 Week High | $6.01 | $10.00 |
Technical Indicators
Market Signals| Indicator | NRXP | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 45.23 | 40.49 |
| Support Level | $2.22 | $1.80 |
| Resistance Level | $2.51 | $2.20 |
| Average True Range (ATR) | 0.19 | 0.24 |
| MACD | 0.04 | 0.04 |
| Stochastic Oscillator | 68.52 | 59.77 |
Price Performance
Historical ComparisonAbout NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.